36 employees
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.
2020
$10M
from 4 investors over 4 rounds
Neuroglee Therapeutics raised $10M on September 9, 2021
Investors: Eisai Asia, Openspace Ventures and EDBI Pte Ltd
Neuroglee Therapeutics raised $2.3M on December 3, 2020
Investors: Eisai Asia